Published in AIDS Weekly, May 13th, 1996
Current therapies for HIV infection, such as zidovudine (AZT), attack the virus after it already has invaded a cell, said study leader William O'Brien, M.D., West Los Angeles VAMC and UCLA associate professor of medicine.
In contrast, O'Brien and his colleagues found that a drug called ALX40-4C appeared to block certain strains of HIV by preventing the virus from entering the cell. "This...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.